Literature DB >> 24721232

Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections.

Nadia Abed1, Patrick Couvreur2.   

Abstract

In the field of antibiotherapy, intracellular infections remain difficult to eradicate mainly due to the poor intracellular penetration of most of the commonly used antibiotics. Bacteria have quickly understood that their intracellular localisation allows them to be protected from the host immune system, but also from the action of antimicrobial agents. In addition, in most cases pathogens nestle in professional phagocytic cells, and can even use them as a 'Trojan horse' to induce a secondary site of infection thereby causing persistent or recurrent infections. Thus, new strategies had to be considered in order to counteract these problems. Amongst them, nanocarriers loaded with antibiotics represent a promising approach. Nowadays, it is possible to encapsulate, incorporate or even conjugate biologically active molecules into different families of nanocarriers such as liposomes or nanoparticles in order to deliver antibiotics intracellularly and hence to treat infections. This review gives an overview of the variety of nanocarriers developed to deliver antibiotics directly into infected cells.
Copyright © 2014 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Antibiotic; Bacteria; Drug delivery; Intracellular infection; Nanoparticle

Mesh:

Substances:

Year:  2014        PMID: 24721232     DOI: 10.1016/j.ijantimicag.2014.02.009

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  54 in total

1.  Nanomedicine in the Management of Microbial Infection - Overview and Perspectives.

Authors:  Xi Zhu; Aleksandar F Radovic-Moreno; Jun Wu; Robert Langer; Jinjun Shi
Journal:  Nano Today       Date:  2014-08-01       Impact factor: 20.722

Review 2.  Nanotechnology in Tuberculosis: State of the Art and the Challenges Ahead.

Authors:  Estefania Grotz; Nancy Tateosian; Nicolas Amiano; Maximiliano Cagel; Ezequiel Bernabeu; Diego A Chiappetta; Marcela A Moretton
Journal:  Pharm Res       Date:  2018-09-20       Impact factor: 4.200

Review 3.  Recalcitrant Staphylococcus aureus Infections: Obstacles and Solutions.

Authors:  Sarah E Rowe; Jenna E Beam; Brian P Conlon
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

Review 4.  Nanoparticle-based local antimicrobial drug delivery.

Authors:  Weiwei Gao; Yijie Chen; Yue Zhang; Qiangzhe Zhang; Liangfang Zhang
Journal:  Adv Drug Deliv Rev       Date:  2017-09-20       Impact factor: 15.470

5.  Treatment of Brucellosis in Guinea Pigs via a Combination of Engineered Novel pH-Responsive Curcumin Niosome Hydrogel and Doxycycline-Loaded Chitosan-Sodium Alginate Nanoparticles: an In Vitro and In Vivo Study.

Authors:  Fatma I Abo El-Ela; Khaled H Hussein; Hossny A El-Banna; Amr Gamal; Sherin Rouby; Ahmed M S Menshawy; El-Shimaa El-Nahass; Shehata Anwar; Mohamed M A Zeinhom; Heba F Salem; Marawa Ahmed Yahia Al-Sayed; Hala A El-Newery; Khaled A M Shokier; Khalid A El-Nesr; H I Hosein
Journal:  AAPS PharmSciTech       Date:  2020-11-18       Impact factor: 3.246

6.  Glyconanomaterials for Combating Bacterial Infections.

Authors:  Olof Ramström; Mingdi Yan
Journal:  Chemistry       Date:  2015-09-29       Impact factor: 5.236

7.  ArtinM Grafted Phospholipid Nanoparticles for Enhancing Antibiotic Cellular Uptake Against Intracellular Infection.

Authors:  Tri Suciati; Safira Nafisa; Tantri Liris Nareswari; Meta Juniatik; Elin Julianti; Marlia Singgih Wibowo; Titah Yudhistira; Ihsanawati Ihsanawati; Yani Triyani; Khairurrijal Khairurrijal
Journal:  Int J Nanomedicine       Date:  2020-11-10

Review 8.  Trends in therapeutic drug conjugates for bacterial diseases: a patent review.

Authors:  Pedro M S D Cal; Maria J Matos; Gonçalo J L Bernardes
Journal:  Expert Opin Ther Pat       Date:  2016-11-23       Impact factor: 6.674

Review 9.  Targeting the hard to reach: challenges and novel strategies in the treatment of intracellular bacterial infections.

Authors:  Nor Fadhilah Kamaruzzaman; Sharon Kendall; Liam Good
Journal:  Br J Pharmacol       Date:  2016-12-07       Impact factor: 8.739

10.  Human neutrophil membrane-derived nanovesicles as a drug delivery platform for improved therapy of infectious diseases.

Authors:  Jin Gao; Xinyue Dong; Yujie Su; Zhenjia Wang
Journal:  Acta Biomater       Date:  2021-01-18       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.